Massachusetts General Hospital;Hematology/ Oncology

Boston, Massachusetts 02114

0 studies enrolling now · 5 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Head and Neck Cancer, Malignant Melanoma, Non-Small Cell Lung Cancer

Studies at this site

• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early
• A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma — Completed
• A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma — Completed
• A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) — Completed